Skip to content
10-Q

Quarterly Report

AMPIO PHARMACEUTICALS, INC.

0001558370-23-019022

← back to feed
Filed
Nov 14, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 10, 2023 832.02K sh
Stock Issued Q3 2023 · Sep 30, 2023 0 sh
Shares Diluted Q3 2023 · Sep 30, 2023 804.16K sh
Shares Diluted Q3 2023 · Sep 30, 2023 804.16K sh
Shares Diluted restated Q3 2023 · Sep 30, 2022 753.62K sh
Shares Diluted restated Q3 2023 · Sep 30, 2022 753.62K sh
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$6.26M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$16.83M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $6.4M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $12.65M
Stockholders Equity Q3 2023 · Sep 30, 2023 $5.38M
Stockholders Equity Q3 2023 · Jun 30, 2023 $6.56M
Stockholders Equity Q3 2023 · Mar 31, 2023 $7.88M
Stockholders Equity Q3 2023 · Dec 31, 2022 $11.79M
Stockholders Equity Q3 2023 · Sep 30, 2022 $13.85M
Stockholders Equity Q3 2023 · Jun 30, 2022 $20.1M
Stockholders Equity Q3 2023 · Mar 31, 2022 $22.25M
Stockholders Equity Q3 2023 · Dec 31, 2021 $27.28M
Current Liabilities Q3 2023 · Sep 30, 2023 $2.27M
Current Liabilities Q3 2023 · Dec 31, 2022 $1.19M
Total Liabilities Q3 2023 · Sep 30, 2023 $2.27M
Total Liabilities Q3 2023 · Dec 31, 2022 $1.8M
Current Assets Q3 2023 · Sep 30, 2023 $7.65M
Current Assets Q3 2023 · Dec 31, 2022 $13.33M
Total Assets Q3 2023 · Sep 30, 2023 $7.65M
Total Assets Q3 2023 · Dec 31, 2022 $13.59M
Eps Diluted Q3 2023 · Sep 30, 2023 −$1.53
Eps Diluted Q3 2023 · Sep 30, 2023 −$8.18
Eps Diluted restated Q3 2023 · Sep 30, 2022 −$10.06
Eps Diluted restated Q3 2023 · Sep 30, 2022 −$25.88
Eps Basic Q3 2023 · Sep 30, 2023 −$1.53
Eps Basic Q3 2023 · Sep 30, 2023 −$8.18
Eps Basic restated Q3 2023 · Sep 30, 2022 −$8.51
Eps Basic restated Q3 2023 · Sep 30, 2022 −$18.73
Rd Expense Q3 2023 · Sep 30, 2023 $329K
Rd Expense Q3 2023 · Sep 30, 2023 $1.2M
Rd Expense Q3 2023 · Sep 30, 2022 $2.75M
Rd Expense Q3 2023 · Sep 30, 2022 $8.18M
Net Income Q3 2023 · Sep 30, 2023 −$1.23M
Net Income Q3 2023 · Sep 30, 2023 −$6.58M
Net Income Q3 2023 · Jun 30, 2023 −$1.37M
Net Income Q3 2023 · Mar 31, 2023 −$3.98M
Net Income Q3 2023 · Sep 30, 2022 −$6.41M
Net Income Q3 2023 · Sep 30, 2022 −$14.12M
Net Income Q3 2023 · Jun 30, 2022 −$2.07M
Net Income Q3 2023 · Mar 31, 2022 −$5.64M